Skip to content
Menu

Leerink Partners Maintains Outperform on Axogen, Raises Price Target to $65

Benzinga Newsdesk 6 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Leerink Partners analyst Mike Kratky maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $56 to $65.

Leerink Partners analyst Mike Kratky maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $56 to $65.

Read at benzinga.com